InvestorsHub Logo
Followers 50
Posts 6907
Boards Moderated 0
Alias Born 01/06/2012

Re: None

Tuesday, 04/04/2017 12:08:55 PM

Tuesday, April 04, 2017 12:08:55 PM

Post# of 403349
Elite Pharmaceuticals Files ANDA for Pain Product

NORTHVALE, N.J., April 04, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that it had filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) for a generic version of a synthetic narcotic analgesic indicated for the management of pain. The branded product and its equivalents had annual sales of over $40 million in 2016 according to IMS Health data.

"With the filing of this ANDA, Elite has three pain product ANDAs under review by the FDA.  The market for these products has combined annual sales of over $1 billion," said Nasrat Hakim, President and CEO of Elite.  "Elite continues developing new generics to grow its business."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News